期刊文献+

年龄≤50岁非前列腺癌男性初始PSA及PSA速度的分布特点分析

Distribution and characteristics of initial PSA and PSA velocity in men younger than 50 years without prostate cancer
原文传递
导出
摘要 目的探讨年龄≤50岁非前列腺癌男性初始PSA及PSA速度的分布特点。方法回顾性分析2001年1月至2009年11月初始PSA检测年龄≤50岁的非前列腺癌患者的PSA值,计算PSA检测≥2次者的PSA速度。研究不同年龄段初始PSA及PSA速度的分布范围,分析初始PSA、初始PSA年龄及PSA速度之间的相关性。用生存分析和log—rank检验比较初始PSA高于和低于中位数2组患者将来PSA≥2.5ng/ml风险的差异。结果4206例非前列腺癌者,初始PSA中位数为0.6ng/ml,其中≥1.0、≥2.5和≥4.0ng/ml者分别1026例(24.4%)、177例(4.2%)和90例(2.1%)。417例PSA检测≥2次者PSA速度的中位数为0.03ng·ml^-1·y^-1,其中≥0.35、≥0.75和≥2.00ng·ml^-1·y^-1者分别为25例(6.0%)、13例(3.1%)和8例(1.9%)。年龄与PSA、年龄与PSA速度、PSA与PSA速度之间均无明显相关性(r值分别为0.019、-0.015和-0.006,P值分别为0.218、0.754和0.897)。395例PSA检测≥2次且初始PSA〈2.5ng/ml者随访3个月~7.1年,中位时间2.0年,初始PSA高于和低于中位数2组患者将来PSA超过2.5ng/ml的风险差异有统计学意义(P〈0.01)。结论年龄≤50岁非前列腺癌男性的中位初始PSA和PSA速度分别为0.6ng/ml和0.03ng·ml^-1·y^-1。初始PSA高于中位数的患者将来PSA超过2.5ng/ml的风险明显增高。 Objective To explore the distribution and characteristics of initial PSA and PSA velocity in men younger than years without prostate cancer. Methods PSA in men younger than 50 years without prostate cancer from January 2001 to November 2009 were retrieved retrospectively from our computer center. PSA velocity was calculated if their PSA was measured twice or more. The distributions of initial PSA and PSA velocity were analyzed. The correlations between initial PSA, initial PSA age, and PSA velocity were also analyzed. Kaplan-meicr and log-rank tests were used to estimate the significant difference at the risk of PSA≥ 2.5 ng/ml after initial PSA measurement, stratified by median initial PSA (0.6 ng/ml). Results A total of 4206 men without prostate cancer were included. The median initial PSA value in these men was0.6 ng/ml. Of these men, 1026 (24.4%), 177 (4.2%), and 90 (2.1%) had an initialPSA≥ 1.0, ≥2.5, and ≥4.0 ng/ml, respectively. A total of 417 men had their PSA measured twice or more. The median PSA velocity in these men was 0.03 ng · ml^-1· year^-1 Of these men, 25 (6.0%), 13 (3.1%), and8 (1.9%) had a PSA velocity ≥0.35, ≥0.75, ≥2.00 ng· ml^-1· year^-1, respectively. There were no direct correlations between initial PSA age and initial PSA, initial PSA age and PSA velocity, and initial PSA and PSA velocity ( correlation coefficient r = 0. 019, - 0. 015, and - 0. 006, respectively; P=0. 218, 0. 754, and 0. 897, respectively). After a follow-up of up to 7. 1 years from baseline PSA measurement, the risk of PSA ≥2.5 ng/ml, stratified by median initial PSA (0.6 ng/ml) was significantly different (log-rank test, P 〈 0. 001 ). Conclusions The median baseline PSA and PSA velocity in men younger than 50 years old without prostate cancer are 0.6 ng/ml and 0.03 ng· ml^-1· year^-1, respectively. Men younger than 50 years old without prostate cancer with an initial PSA higher than median (0.6 ng/ml) have a subsequently higher risk of PSA value ≥2.5 ng/ml.
出处 《中华泌尿外科杂志》 CAS CSCD 北大核心 2011年第7期477-481,共5页 Chinese Journal of Urology
关键词 前列腺癌 肿瘤 初始PSA PSA速度 年轻男性 Prostatic neoplasms Carcinoma Initial PSA PSA velocity Young men
  • 相关文献

参考文献17

  • 1Fang J, Metter EJ, Landis P, et al. Low levels cific antigen predict long-term risk of prostate from the Baltimore Longitudinal Study of Aging 58: 411-416. of prostate-spe- cancer : results Urology, 2001,.
  • 2Greene KL, Albertsen PC, Babaian RJ, et al. Prostate specific antigen best practice statement: 2009 update. J Urol, 2009, 182 : 2232-2241.
  • 3National Comprehensive Cancer Network. NCCN stresses importance of PSA testing in high-risk men [ EB/OL]. (2009-05-10) [ 2010-11-08 ]. www. nccn. org/about/news/newsinfo, asp? NewslD =218.
  • 4Connolly D, Black A, Murray LJ, et al. Methods of calcula-ting prostate-specific antigen velocity. Eur Urol, 2007, 52: 1044-1050.
  • 5Andriole GL, Crawford ED, Grubb RL 3rd, et al. Mortality re- suits from a randomized prostate-cancer screening trial. N Engl J Med, 2009, 360: 1310-1319.
  • 6Schroder FH, Hugosson J, Roobol M J, et al. Screening and prostate-cancer mortality in a randomized european study. N Engl J Med, 2009, 360: 1320-1328.
  • 7Scott Morey S. Aua issues a policy report on psa monitoring. The American Urological Association. Am Faro Physician, 2000, 62 : 883 -884.
  • 8Lilja H, Ulmert D, Bjork T, et al. Long-term prediction of prostare cancer up to 25 years before diagnosis of prostate caneer using prostate kallikreins measured at age 44 to 50 years. J Clin Oneol, 2007, 25: 4-31-436.
  • 9Tang P, Sun L, Uhlman MA, et al. Initial prostate specific anti- gen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. J Urol, 2010, 153 : 946-950.
  • 10李鸣,张思维,马建辉,陈万青,那彦群.中国部分市县前列腺癌发病趋势比较研究[J].中华泌尿外科杂志,2009,30(6):368-370. 被引量:171

二级参考文献14

  • 1张思维,陈万青,孔灵芝,李连弟,鲁凤珠,李光琳,孟佳,赵平.中国部分市县1998~2002年恶性肿瘤的发病与死亡[J].中国肿瘤,2006,15(7):430-448. 被引量:171
  • 2李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第1卷(1988-1992).北京:中国医药科技出版社,2002:263-289.
  • 3李连弟,饶克勤.中国试点市县恶性肿瘤的发病与死亡第2卷(1993-1997).北京:中国医药科技出版社,2003:269-295.
  • 4李连弟,饶克勤,孔灵芝,等.中国试点市县恶性肿瘤的发病与死亡第3卷(1999-2002).北京:人民卫生出版社,2007:314-316.
  • 5Parkin DM, Whelan SL, Ferlay J, et al. Cancer incidence in five continents. Vol. VIII. IARC Scientific Publication No. 155. Lyon: IARC, 2002: 745-747.
  • 6Curado MP, Edwards B, Shin HR, et al. Cancer incidence in five continents. Vol. IX. IARC Scientific Publication No. 160. Lyon: IARC, 2008.
  • 7Jensen OM, Parkin DM, MacLennan R, et al. Cancer registration: principles and methods. IARC Scientific Publication No. 95. Lyon.. IARC, 1991.. 101-107.
  • 8Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IARC Technical Report No. 19. Lyon.. IARC, 1994: 35-49.
  • 9Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC Technical Report No. 42. Lyon: IARC, 2005: 11-38.
  • 10Felay J. The IARCcrgTools program, http://www, iacr. com. fr/iarccrgtools, htm. IACR. Lyon. 2006.

共引文献177

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部